TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) — As Canada enters peak respiratory illness season, Canadians now have access to the first Health Canada-approved at-home COVID-19 and Influenza A/B combination ...
TORONTO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- As Canada enters peak respiratory illness season, Canadians now have access to the first Health Canada-approved at-home COVID-19 and Influenza A/B ...
With a second late-stage trial win for its investigational HIV combo in the books, Gilead Sciences is moving full steam ahead toward regulatory filings for the novel HIV regimen. In Gilead's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback